<DOC>
	<DOCNO>NCT00495820</DOCNO>
	<brief_summary>The purpose study determine efficacy methylphenidate placebo treat apathy patient Alzheimer 's dementia . Apathy one early profound disturbance occur Alzheimer 's dementia ( AD ) . Hypotheses : 1 . Methylphenidate ( MPH ) improve apathy significantly placebo AD . 2 . Successful treatment apathy improve Instrumental Activities Daily Living ( IADLs ) , caregiver burden .</brief_summary>
	<brief_title>Methylphenidate Apathy Alzheimer 's Dementia : A Controlled Study</brief_title>
	<detailed_description>Objective : Apathy one early profound disturbance occur Alzheimer 's dementia ( AD ) . Based promising preliminary data open-label pilot study propose double blind , placebo-controlled randomized clinical trial methylphenidate treatment apathy AD . Research Design : Randomized double blind , placebo-controlled study evaluate effect methylphenidate apathy also impact improvement apathy caregiver burden functional status . Hypotheses : 1 . Methylphenidate improve apathy significantly placebo AD . 2 . Successful treatment apathy improve Instrumental Activities Daily Living ( IADLs ) , caregiver burden . Methodology : 60 patient apathy context AD recruit next three year . In proposed study patient recruit relevant clinic Omaha Veterans Affairs Medical Center ( VAMC ) include clinic Geriatric Psychiatry , Neurology , Primary Care Geriatric Medicine . 30 patient AD apathy randomly assign placebo MPH . All patient methylphenidate arm start 5mg twice daily titrate 10mg twice daily two week . Patients continue arm 12 week follow 2-week discontinuation phase . Patients assess regular interval use Apathy Evaluation Scale , Instrumental Activities Daily Living , Zarit Burden Scale Mini Mental State Examination . Findings : None , study complete . Clinical Relationships : While memory key cognitive problem AD , apathy key behavioral problem . Apathy characterize indifference , disengagement , passivity , lack enthusiasm , interest , empathy interpersonal involvement . Apathy common , one earliest probably persistent behavioral problem AD . Apathy disturb behavior caregiver great impact functional status caregiver burden . Despite , apathy behavioral problem largely neglect . Most research direct towards behavioral problem dementia target towards visible behavior agitation , psychosis . Remarkably , publish randomize , double blind , placebo control study treatment apathy associate AD . Impact/Significance : Around 1.4 million veteran suffer apathy association AD . Apathy strong predictor functional decline caregiver burden . Treatment apathy remarkably understudied absolutely critical allow veteran maximize functional status , social engagement quality life , thus delay placement assist live nursing home setting .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Diagnosis dementia Alzheimer type ( DSMIV Text Revision ( TR ) criterion ) 2 . Minimental state examination ( MMSE ) &gt; 18 , &lt; 29 3 . Apathy Evaluation Scale ( AES ) score 40 4 . Ability provide inform consent either patient caregiver . 5 . If subject treat antidepressant , stable dose antidepressant least two month prior enrollment study . 6 . If subject treat cholinesterase inhibitor memantine , stable dose medication least four month prior enrollment study . 1 . Patient currently take methylphenidate hypersensitivity prior significant adverse event methylphenidate . 2 . Patients currently take Adderall ( amphetamine mixed salt ) Dexedrine ( dextroamphetamine sulphate ) amphetamine product . 3 . Uncontrolled hypertension ( BP &gt; 140/90 ) tachycardia ( 100 ) screen visit 4 . Patients frontotemporal dementia 5 . Patients meet criterion Major Depressive Disorder Mini International Neuropsychiatric Inventory ( MINI ) 6 . Patients active psychosis determine MINI 7 . Patients currently treat antipsychotic 8 . History uncontrolled seizure disorder 9 . History malignant hypertension , symptomatic cardiovascular disease , cardiomyopathy , known structural cardiac defect medically unstable arrhythmia . 10 . History Tourette 's syndrome presence motor tic 11 . Patients glaucoma 12 . Patients take monoamine oxidase inhibitor ( MAOIs ) 13 . Patient take clonidine</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Apathy</keyword>
	<keyword>Dementia</keyword>
	<keyword>Methylphenidate</keyword>
</DOC>